Search

Pexidartinib is the first drug approved specifically to treat tenosynovial giant cell tumor.

… Monday, August 5, 2019 Summary Pexidartinib is the first drug approved specifically to treat the rare joint tumor tenosynovial giant cell tumor, which is also known as pigmented villonodular synovitis. On August 2, the US Food and Drug Administration announced that it had approved pexidartinib (Turalio

Learn from MSK experts about how to quit smoking if you have cancer. It starts with having honest conversations about smoking and nicotine addiction.

… Friday, April 5, 2019 Summary Four MSK experts share strategies specifically for people with cancer to help them quit smoking. Most people know that smoking is the leading cause of cancer. But there is much less awareness among people with cancer — and their doctors — that smoking is associated with

Memorial Sloan Kettering Cancer Center has filed an application with the New York State Department of Health to open a freestanding outpatient facility in Harrison, New York. If approved, the new 114,000-square-foot treatment facility will offer area residents the most advanced cancer care services, closer to home.

… Monday, January 31, 2011 Memorial Sloan Kettering Cancer Center has filed an application with the New York State Department of Health to open a freestanding outpatient facility in Harrison, New York. If approved, the new 114,000-square-foot treatment facility will offer area residents the most advanced

Despite the promise of eventually using artificial intelligence to detect melanoma, much more research and development are needed, MSK experts find.

… Thursday, May 19, 2022 When it comes to smartphone technologies, today there’s an app for just about everything: You can play chess, learn to speak Mandarin, or map the best driving route to the airport. Health is a huge category for apps, but many of these programs don’t have the science to back their

Cancer DNA taken from spinal fluid could serve as a liquid biopsy that provides information on brain tumor mutations.

… Wednesday, January 23, 2019 Summary Studying mutational changes that occur in brain tumors has been difficult. A new approach involves analyzing cancer DNA that the tumor sheds into the fluid surrounding the brain and spinal cord. This fluid can be collected in biopsies to help with diagnosis and choosing

New findings from researchers at the Sloan Kettering Institute provide insight into a fundamental biological process called the epithelial-mesenchymal transition.

… Wednesday, January 8, 2020 Summary Scientists at the Sloan Kettering Institute have identified the molecular cues that control a fundamental biological process called the epithelial-to-mesenchymal transition. The results may inform the development of therapies designed to target diseases in which this

斯隆凯特琳研究所的研究人员的新发现，为深入了解一种被称为上皮-间质转化的基本生物学过程提供了重要思路。斯隆凯特琳研究所的研究人员的新发现，为深入了解一种被称为上皮-间质转化的基本生物学过程提供了重要思路。

… Wednesday, January 8, 2020 总结 斯隆·凯特琳研究所 (Sloan Kettering Institute) 的科学家已经确定了控制被称为上皮-间质转化这一基本生物学过程的分子线索。该研究结果可能为开发旨在针对这一过程出错的疾病的疗法提供重要的信息。 人体有 70% 是水，但我们不会像花园里扎破的水管那样漏水，这一点是十分不可思议的。我们应该感谢表皮细胞，让我们的内部和外部均保持紧密密封。 上皮细胞结合在一起形成扁平、连续的壁。这些壁排列在身体内外两侧。它们不仅保证重要的体液不会从体内流失，还能防止有害微生物进入体内。 上皮组织是在胚胎发育过程中形成的，必须在整个生命过程中进行维护和修复

Learn how immunotherapy holds promise for transforming the treatment of gynecologic cancers.

… Friday, December 29, 2017 Summary MSK scientists and doctors played a leading role in developing immunotherapies that have transformed the treatment of melanoma, lung cancer, and other cancers. Now this therapeutic approach is giving new hope to people with gynecologic cancers, including ovarian cancer

A family of drugs developed at MSK targets disrupted processes in cells in diseases related to aging.

… Thursday, March 1, 2018 Summary Cancer and Alzheimer’s are both diseases of aging. So it’s not entirely unexpected that a type of drug developed to target proteins in cells that get disrupted over time might work on both conditions. Like cancer, Alzheimer’s disease involves changes in proteins. When

Advances in diagnostic and imaging modalities are making it possible to detect complex melanoma earlier, with greater accuracy, and are helping guide surgical approaches and patient monitoring plans.

… Wednesday, October 12, 2016 Early detection of melanoma is paramount to determine the best treatment approach and achieve a potential cure. Advances in diagnostic and imaging modalities are making it possible to detect melanoma earlier, with greater accuracy, and are helping guide surgical approaches